Related Experiment Videos
[Efficient expression of human C1-inhibitor in CHO cells by using a dicistronic expression vector]
Summary
Researchers successfully produced recombinant human C1-INH (complement 1 inhibitor) in CHO cells. The expressed protein demonstrated biological activity, confirming its potential for therapeutic applications.
Area of Science:
- Biotechnology and Molecular Biology
- Protein Expression and Engineering
Context:
- The development of recombinant proteins is crucial for therapeutic and research applications.
- Efficient expression systems are needed to produce functional therapeutic proteins like C1-INH.
Purpose:
- To establish a stable expression system for human C1-INH (complement 1 inhibitor) in mammalian cells.
- To confirm the expression and biological activity of the recombinant C1-INH.
Summary:
- A full-length human C1-INH cDNA was cloned into an expression vector (pED) and transfected into CHO-dhfr- cells.
- Stable C1-INH expressing cell clones were generated and confirmed by Northern blot, immunoprecipitation, and Western blot.
- Quantification via ELISA showed 0.4 microgram/ml expression, and biological activity was verified by C1 estrolytic inhibition.
Impact:
- This study provides a robust method for producing biologically active recombinant human C1-INH.
- The established expression system can facilitate further research and development of C1-INH-based therapies.